FIELD: virology, biotechnology. SUBSTANCE: invention relates to preparing a recombinant ALFA-2-interferon-base lyophilized preparation where serum component containing antibodies to one or some pathogens of viral diseases is added. Immune sera or immunoglobulins taken at final concentrations 0.5-10.0% by total protein can be used as a serum component. Method can be used for preparing curative-prophylaxis immune biological preparations showing antiviral effect. EFFECT: enhanced antiviral activity, increased stability at storage. 2 cl, 3 tbl
Authors
Dates
1998-11-10—Published
1995-11-03—Filed